{"id":7961,"date":"2025-10-29T23:02:33","date_gmt":"2025-10-29T23:02:33","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/10\/29\/biotech-news-genesis-natera-bridgebio-nvidia\/"},"modified":"2025-10-29T23:02:33","modified_gmt":"2025-10-29T23:02:33","slug":"biotech-news-genesis-natera-bridgebio-nvidia","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/10\/29\/biotech-news-genesis-natera-bridgebio-nvidia\/","title":{"rendered":"STAT+: Natera, known for spotting\u00a0cancer recurrence, wades into early detection"},"content":{"rendered":"<p>    STAT+: Natera, known for spotting\u00a0cancer recurrence, wades into early detection<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p><em>Want to stay on top of the science and politics driving biotech today?\u00a0<a href=\"https:\/\/www.statnews.com\/signup\/readout\/\">Sign up<\/a>\u00a0to get our biotech newsletter in your inbox.<\/em><\/p>\n<p>Good morning. It seems everyone I know has been getting sick lately \u2014 hope you are all taking care of yourselves! Onto the news today.<\/p>\n<h2 class=\"wp-block-heading\" id=\"h-bridgebio-notches-another-phase-3-win\">BridgeBio notches another Phase 3 win<\/h2>\n<p>BridgeBio said this morning that its investigational drug succeeded in a late-stage trial of patients with autosomal dominant hypocalcemia type 1, a rare genetic condition\u00a0that causes low calcium levels in the blood.<\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2025\/10\/29\/biotech-news-genesis-natera-bridgebio-nvidia\/?utm_campaign=rss\">Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Elaine Chen<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2025\/10\/29\/biotech-news-genesis-natera-bridgebio-nvidia\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>STAT+: Natera, known for spotting\u00a0cancer recurrence, wades into early detection Want to stay on top of the science and politics driving biotech today?\u00a0Sign up\u00a0to get our biotech newsletter in your inbox. Good morning. It seems everyone I know has been getting sick lately \u2014 hope you are all taking care of yourselves! Onto the news [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2194,2154,58,2208,2209,2176,858,2207],"tags":[2150],"class_list":["post-7961","post","type-post","status-publish","format-standard","hentry","category-biotech","category-biotechnology","category-business","category-drug-development","category-drug-prices","category-pharma","category-research","category-the-readout","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/7961"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=7961"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/7961\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=7961"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=7961"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=7961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}